✦ LIBER ✦

Rank-based predictors for response and prognosis of neoadjuvant taxane-anthracycline-based chemotherapy in breast cancer

✍ Scribed by Zhang, Lin; Hao, Chunxiang; Shen, Xiaopei; Hong, Guini; Li, Hongdong; Zhou, Xianxiao; Liu, ChunYang; Guo, Zheng

Book ID: 121634089
Publisher: Springer US
Year: 2013
Tongue: English
Weight: 308 KB
Volume: 139
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-013-2566-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bisphosphonates and pathologic complete

Bisphosphonates and pathologic complete response to taxane- and anthracycline-based neoadjuvant chemotherapy in patients with breast cancer

✍ Mariana Chavez-MacGregor; Erika Brown; Xiudong Lei; Jennifer Litton; Funda Meric 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB 👁 2 views

Predictors of inflammation in response t

Predictors of inflammation in response to anthracycline-based chemotherapy for breast cancer

✍ Paul J. Mills; Sonia Ancoli-Israel; Barbara Parker; Loki Natarajan; Suzi Hong; S 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 146 KB

CD24 Polymorphisms Cannot Predict Pathol

CD24 Polymorphisms Cannot Predict Pathologic Complete Response to Anthracycline- and Taxane-Based Neoadjuvant Chemotherapy in Breast Cancer

✍ Zhou, Xin 📂 Article 📅 2014 🏛 CIG Media Group, LP. 🌐 English ⚖ 802 KB

Accuracy of MRI for treatment response a

Accuracy of MRI for treatment response assessment after taxane- and anthracycline-based neoadjuvant chemotherapy in HER2-negative breast cancer

✍ Charehbili, A.; Wasser, M.N.; Smit, V.T.H.B.M.; Putter, H.; van Leeuwen-Stok, A. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 375 KB

Clinical implications of HER-2 and P53 i

Clinical implications of HER-2 and P53 in taxane-based and anthracycline-based neoadjuvant chemotherapy in breast cancer

✍ Wang, Xiaolan ;Yao, Fan ;Liu, Nan ;Wu, Yunfei ;Zheng, Xinyu ;Li, Jiguang ;Liu, C 📂 Article 📅 2008 🏛 Springer-Verlag ⚖ 338 KB

CD24 Ala57Val polymorphism predicts path

CD24 Ala57Val polymorphism predicts pathologic complete response to sequential anthracycline- and taxane-based neoadjuvant chemotherapy for primary breast cancer

✍ Frederik Marmé; Wiebke Werft; Anne Walter; Sascha Keller; Xiaoli Wang; Axel Benn 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 653 KB